Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
Year: 2009
Type: article
Source: American Journal Of Pathology
Authors: Minghua Wu, Denisa S. Melichian, Eric Chang, Matthew Warner-Blankenship, Asish K. Ghosh, John Varga
Institution: Northwestern University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2024059588
